Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02740127Phase 3Completed
Phase 3, randomised, single-blind trial of ropivacaine, epinephrine, dexamethasone and clonidine in postoperative pain (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Post-Operative Pain Medication Usage in Post Anesthesia Care Unit (PACU) at 24 hours. Started Jun 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02740127.